A validated risk model for overall survival in relapsed/refractory chronic lymphocytic leukemia applicable to patients treated with novel therapies and standard of care Meeting Abstract


Authors: Soumerai, J. D.; Ni, A.; Darif, M.; Londhe, A.; Xing, G.; Huang, J.; Lin, M.; Byrd, J. C.; Chanan-Khan, A. A.; Furman, R. R.; Hallek, M.; Hillmen, P.; Jones, J.; Sharman, J. P.; Ferrante, L.; Reddy, V.; Dreiling, L. K.; Adewoye, H.; Dubowy, R.; Howes, A.; James, D. F.; Zelenetz, A. D.
Abstract Title: A validated risk model for overall survival in relapsed/refractory chronic lymphocytic leukemia applicable to patients treated with novel therapies and standard of care
Meeting Title: 59th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 130
Issue: Suppl. 1
Meeting Dates: 2017 Dec 9-12
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2017-12-07
Language: English
ACCESSION: WOS:000432419703313
PROVIDER: wos
Notes: Meeting Abstract: 4303 -- Source: Wos
MSK Authors
  1. Andrew D Zelenetz
    551 Zelenetz
  2. Ai   Ni
    47 Ni